Literature DB >> 18795942

Overexpression of interleukin-12 and T helper 1 predominance in lupus nephritis.

M Tucci1, L Lombardi, H B Richards, F Dammacco, F Silvestris.   

Abstract

Imbalance of cytokine homeostasis is a prominent feature of both experimental and human systemic lupus erythematosus (SLE). Because interleukin (IL)-12 promotes interferon (IFN)-gamma production leading to polarization of peripheral cells toward a T helper (Th) 1 phenotype, we investigated its role in lupus nephritis (LN). Soluble Th1 and Th2 cytokines were measured by enzyme-linked immunosorbent assay (ELISA) in sera and urines of SLE patients and controls. Th1/Th2 peripheral lymphocyte polarization was determined by flow cytometry. Glomerular accumulation of IL-12 was evaluated by immunohistochemistry, whereas urinary IL-12 was evaluated by ELISA. Higher serum IL-12 levels in SLE were associated with LN, whereas IL-4 was unrelated to the renal damage. Peripheral cells from LN patients showed a Th1 phenotype with a high IFN-gamma expression that paralleled the severity of renal damage. IL-12 was present within glomerular mononuclear cells in classes IV and V LN, and its accumulation was correlated strongly with urinary levels. IL-12 overexpression in SLE may contribute to the development of LN. Both serum and urinary IL-12 elevation reflect its glomerular production and parallel Th1 polarization of peripheral T cells and high IFN-gamma production. In SLE patients, IL-12 measurement may thus be predictive of the development of LN.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18795942      PMCID: PMC2612719          DOI: 10.1111/j.1365-2249.2008.03758.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  41 in total

1.  IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(lpr) mice.

Authors:  A Schwarting; G Tesch; K Kinoshita; R Maron; H L Weiner; V R Kelley
Journal:  J Immunol       Date:  1999-12-15       Impact factor: 5.422

2.  Predominance of Th1 immune response in diffuse proliferative lupus nephritis.

Authors:  K Masutani; M Akahoshi; K Tsuruya; M Tokumoto; T Ninomiya; T Kohsaka; K Fukuda; H Kanai; H Nakashima; T Otsuka; H Hirakata
Journal:  Arthritis Rheum       Date:  2001-09

3.  Interferon-gamma is required for lupus nephritis in mice treated with the hydrocarbon oil pristane.

Authors:  H B Richards; M Satoh; J C Jennette; B P Croker; H Yoshida; W H Reeves
Journal:  Kidney Int       Date:  2001-12       Impact factor: 10.612

4.  Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis.

Authors:  Guillermo Pérez DE Lema; Holger Maier; Elena Nieto; Volker Vielhauer; Bruno Luckow; Francisco Mampaso; Detlef Schlöndorff
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

5.  Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus.

Authors:  C K Wong; C Y Ho; E K Li; C W Lam
Journal:  Lupus       Date:  2000       Impact factor: 2.911

6.  IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.

Authors:  Eriya Kikawada; Deborah M Lenda; Vicki R Kelley
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

7.  Serum IL-12 in systemic lupus erythematosus: absence of p70 heterodimers but presence of p40 monomers correlating with disease activity.

Authors:  B R Lauwerys; J Van Snick; F A Houssiau
Journal:  Lupus       Date:  2002       Impact factor: 2.911

8.  Inflammatory cytokine gene expression in the urinary sediment of patients with lupus nephritis.

Authors:  Rebecca Wing-Yan Chan; Lai-Shan Tam; Edmund Kwok-Ming Li; Fernand Mac-Moune Lai; Kai-Ming Chow; Ka-Bik Lai; Philip Kam-Tao Li; Cheuk-Chun Szeto
Journal:  Arthritis Rheum       Date:  2003-05

9.  Elevated production of interleukin-18 is associated with renal disease in patients with systemic lupus erythematosus.

Authors:  C K Wong; C Y Ho; E K Li; L S Tam; C W K Lam
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

10.  IL-23 drives a pathogenic T cell population that induces autoimmune inflammation.

Authors:  Claire L Langrish; Yi Chen; Wendy M Blumenschein; Jeanine Mattson; Beth Basham; Jonathan D Sedgwick; Terrill McClanahan; Robert A Kastelein; Daniel J Cua
Journal:  J Exp Med       Date:  2005-01-17       Impact factor: 14.307

View more
  39 in total

1.  Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus.

Authors:  Hiroshi Kato; Andras Perl
Journal:  J Immunol       Date:  2014-03-28       Impact factor: 5.422

Review 2.  Anti-ribosomal P antibodies and lupus nephritis.

Authors:  Shunsei Hirohata
Journal:  Clin Exp Nephrol       Date:  2011-06-07       Impact factor: 2.801

Review 3.  Re-Examining Neutrophil Participation in GN.

Authors:  Dawn J Caster; David W Powell; Irina Miralda; Richard A Ward; Kenneth R McLeish
Journal:  J Am Soc Nephrol       Date:  2017-06-15       Impact factor: 10.121

4.  Innate lymphoid cell disturbance with increase in ILC1 in systemic lupus erythematosus.

Authors:  Chaohuan Guo; Mianjing Zhou; Siyuan Zhao; Yuefang Huang; Shuang Wang; Rong Fu; Mengyuan Li; Tengyue Zhang; Felicia Gaskin; Niansheng Yang; Shu Man Fu
Journal:  Clin Immunol       Date:  2019-03-26       Impact factor: 3.969

5.  Effect of Sanqi Oral Liquid on the expressions of CD4⁺, CD8⁺ and CD68⁺ cells in 5/6 nephrectomized rats with chronic renal failure.

Authors:  Fang-Ning Wei; Zi-Lin Chen; Hai-Feng Yang; Ling Han; Hai-Ming Ding; Shi-Gui Deng; Run-Mei Ou; Ai-Hua Ou; Yan-Fen Liang; Zi-Heng Hu; Jian Wang; Xiao-Hong Yang; Ni-Zhi Yang
Journal:  Chin J Integr Med       Date:  2012-12-03       Impact factor: 1.978

6.  IFN-gamma AU-rich element removal promotes chronic IFN-gamma expression and autoimmunity in mice.

Authors:  Deborah L Hodge; Cyril Berthet; Vincenzo Coppola; Wolfgang Kastenmüller; Matthew D Buschman; Paul M Schaughency; Hidekazu Shirota; Anthony J Scarzello; Jeff J Subleski; Miriam R Anver; John R Ortaldo; Fanching Lin; Della A Reynolds; Michael E Sanford; Philipp Kaldis; Lino Tessarollo; Dennis M Klinman; Howard A Young
Journal:  J Autoimmun       Date:  2014-02-28       Impact factor: 7.094

Review 7.  Cytokine overproduction, T-cell activation, and defective T-regulatory functions promote nephritis in systemic lupus erythematosus.

Authors:  Marco Tucci; Stefania Stucci; Sabino Strippoli; Francesco Silvestris
Journal:  J Biomed Biotechnol       Date:  2010-06-29

8.  Flow cytometry analysis of glucocorticoid receptor expression and binding in steroid-sensitive and steroid-resistant patients with systemic lupus erythematosus.

Authors:  Juan Du; Min Li; Denghai Zhang; Xiaoyan Zhu; Weiwei Zhang; Wei Gu; Yinglu Feng; Xiaofeng Zhai; Changquan Ling
Journal:  Arthritis Res Ther       Date:  2009-07-14       Impact factor: 5.156

Review 9.  Biomarkers for lupus nephritis: a critical appraisal.

Authors:  Chi Chiu Mok
Journal:  J Biomed Biotechnol       Date:  2010-04-19

Review 10.  The multi-faceted influences of estrogen on lymphocytes: toward novel immuno-interventions strategies for autoimmunity management.

Authors:  Ebru Karpuzoglu; Moncef Zouali
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.